Software System with Applications in Clinical Prognosis, Personalized Medicine and Clinical Research
Posted Jul 22 2010 5:00pm
Description of Invention: Available for licensing is software that can provide prognostic information for different diseases and in particular for cancer. The software can determine whether a particular genotype has a significant association with survival time for an individual receiving treatment. For example, it can determine if a specific genetic pattern is associated with an increased or decreased time to recurrence of a particular type of cancer for patients on a given treatment regimen.
Applications:
Applications in clinical research:
Studying relationship between genotypes and survival times
Evaluation of treatment regimens
Applications in drug discovery programs
Clinical prognosis
Personalized medicine
Development Status:
The invention has been fully developed.
The software will be readily available in executable form if so requested.
Inventors: Brian T Luke (NCI)
Patent Status: HHS, Reference No. E-182-2010/0
Software -- patent protection is not being pursued for this technology
Licensing Status: Available for licensing.
Collaborative Research Opportunity: The NCI is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize this technology. Please contact John Hewes, Ph.D. at 301-435-3121 or hewesj@mail.nih.gov for more information.
For Additional Information Please Contact: Michael Shmilovich Esq. NIH Office of Technology Transfer 6011 Executive Blvd. Suite 325, Rockville, MD 20852 United States Email: shmilovm@mail.nih.gov Phone: 301-435-5019 Fax: 301-402-0220
Description of Invention:
Available for licensing is software that can provide prognostic information for different diseases and in particular for cancer. The software can determine whether a particular genotype has a significant association with survival time for an individual receiving treatment. For example, it can determine if a specific genetic pattern is associated with an increased or decreased time to recurrence of a particular type of cancer for patients on a given treatment regimen.
Applications:
Development Status:
Inventors:
Brian T Luke (NCI)
Patent Status:
HHS, Reference No. E-182-2010/0
Software -- patent protection is not being pursued for this technology
Licensing Status:
Available for licensing.
Collaborative Research Opportunity:
The NCI is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize this technology. Please contact John Hewes, Ph.D. at 301-435-3121 or hewesj@mail.nih.gov for more information.
Portfolios:
Devices/Instrumentation
Devices/Instrumentation - Software
For Additional Information Please Contact:
Michael Shmilovich Esq.
NIH Office of Technology Transfer
6011 Executive Blvd. Suite 325,
Rockville, MD 20852
United States
Email: shmilovm@mail.nih.gov
Phone: 301-435-5019
Fax: 301-402-0220
Ref No: 2136
Updated: 07/2010